Adipose‑derived mesenchymal stem cell exosomes inhibit transforming growth factor‑β1‑induced collagen synthesis in oral mucosal fibroblasts

Liu,Junjie; Li,Fuxingzi; Liu,Binjie; Yao,Zhigang; Li,Long; Liu,Gui; Peng,Lei; Wang,Yuxin; Huang,Junhui

doi:10.3892/etm.2021.10854

Adipose‑derived mesenchymal stem cell exosomes inhibit transforming growth factor‑β1‑induced collagen synthesis in oral mucosal fibroblasts

Authors:
- Junjie Liu
- Fuxingzi Li
- Binjie Liu
- Zhigang Yao
- Long Li
- Gui Liu
- Lei Peng
- Yuxin Wang
- Junhui Huang
View Affiliations

Affiliations: Hunan Key Laboratory of Oral Health Research, Hunan Xiangya Stomatological Hospital, Central South University, Changsha, Hunan 410000, P.R. China, Department of Endocrinology and Metabolism, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. China, Department of Urban Palliative Home Care, Grey Nuns Community Hospital, Edmonton, AB T5J3E4, Canada, Department of Stomatology, Changsha Central Hospital, Changsha, Hunan 410018, P.R. China
Published online on: October 11, 2021 https://doi.org/10.3892/etm.2021.10854
Article Number: 1419
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Oral submucosal fibrosis (OSF) is a potentially malignant oral disorder that requires the further development of advanced treatment strategies. TGF‑β1 has been reported to be the main trigger for the increased collagen production and reduced activity of matrix degradation pathways in OSF. Exosomes are key mediators of paracrine signaling that have been proposed for direct use as therapeutic agents for tissue repair and regeneration. The present study aimed to investigate the effects of human adipose‑derived mesenchymal stem cell (ADSC) exosomes (ADSC‑Exos) on TGF‑β1‑treated oral fibroblasts in vitro and to unravel the potential underlying mechanism of action. Oral mucosal fibroblasts were obtained from the buccal tissues of patients without OSF during extraction of the third molar. ADSCs were obtained from three healthy female individuals during liposuction procedures. ADSC‑Exos were isolated by ultracentrifugation and identified by electron microscopy, nanoparticle tracking and western blotting. Immunofluorescence and immunocytochemistry staining were performed to measure the expression levels of vimentin and α‑smooth muscle actin in the fibroblasts. Reverse transcription‑quantitative PCR and western blotting were used to determine the expression levels of mRNAs and proteins associated with collagen production. The p38 MAPK activator anisomycin was used to identify the underlying mechanisms of the effects of ADSC‑Exos on TGF‑β1‑induced collagen synthesis in oral mucosal fibroblasts. The results of the present study revealed that ADSC‑Exos exhibited a cup‑ or sphere‑shaped morphology, with a mean diameter of 58.01±16.17 nm. ADSC‑Exos were also found to be positive for CD63 and tumor susceptibility 101 expression. ADSC‑Exos treatment reversed the TGF‑β1‑induced upregulation of collagen I and III protein expression. In addition, in the presence of TGF‑β1, the expression levels of collagen type I α 1 chain and collagen type III α 1 chain mRNA were downregulated, whilst the expression levels of matrix metalloproteinase (MMP)1 and MMP3 were upregulated following ADSC‑Exos treatment. The TGF‑β1‑induced upregulation in the phosphorylation of p38 in addition to the increased protein expression of collagens I and III were also reversed in fibroblasts following ADSC‑Exos treatment. However, anisomycin treatment alleviated these ADSC‑Exos‑induced changes. In conclusion, findings from the present study suggest that ADSC‑Exos may represent a promising strategy for OSF treatment by targeting the p38 MAPK signaling pathway.

View Figures

View References

1	Yang PY, Chen YT, Wang YH, Su NY, Yu HC and Chang YC: Malignant transformation of oral submucous fibrosis in Taiwan: A nationwide population-based retrospective cohort study. J Oral Pathol Med. 46:1040–1045. 2017.PubMed/NCBI View Article : Google Scholar
2	Pindborg JJ and Sirsat SM: Oral submucous fibrosis. Oral Surg Oral Med Oral Pathol. 22:764–779. 1966.PubMed/NCBI View Article : Google Scholar
3	Shen YW, Shih YH, Fuh LJ and Shieh TM: Oral Submucous Fibrosis: A Review on Biomarkers, Pathogenic Mechanisms, and Treatments. Int J Mol Sci. 21(7231)2020.PubMed/NCBI View Article : Google Scholar
4	Arakeri G, Rai KK, Hunasgi S, Merkx MA, Gao S and Brennan PA: Oral submucous fibrosis: An update on current theories of pathogenesis. J Oral Pathol Med. 46:406–412. 2017.PubMed/NCBI View Article : Google Scholar
5	Yoithapprabhunath TR, Maheswaran T, Dineshshankar J, Anusushanth A, Sindhuja P and Sitra G: Pathogenesis and therapeutic intervention of oral submucous fibrosis. J Pharm Bioallied Sci. 5 (Suppl 1):S85–S88. 2013.PubMed/NCBI View Article : Google Scholar
6	Hashimoto S, Gon Y, Takeshita I, Matsumoto K, Maruoka S and Horie T: Transforming growth Factor-beta1 induces phenotypic modulation of human lung fibroblasts to myofibroblast through a c-Jun-NH2-terminal kinase-dependent pathway. Am J Respir Crit Care Med. 163:152–157. 2001.PubMed/NCBI View Article : Google Scholar
7	Wei Y, Kim TJ, Peng DH, Duan D, Gibbons DL, Yamauchi M, Jackson JR, Le Saux CJ, Calhoun C, Peters J, et al: Fibroblast-specific inhibition of TGF-β1 signaling attenuates lung and tumor fibrosis. J Clin Invest. 127:3675–3688. 2017.PubMed/NCBI View Article : Google Scholar
8	Tilakaratne WM, Klinikowski MF, Saku T, Peters TJ and Warnakulasuriya S: Oral submucous fibrosis: Review on aetiology and pathogenesis. Oral Oncol. 42:561–568. 2006.PubMed/NCBI View Article : Google Scholar
9	Rajalalitha P and Vali S: Molecular pathogenesis of oral submucous fibrosis - a collagen metabolic disorder. J Oral Pathol Med. 34:321–328. 2005.PubMed/NCBI View Article : Google Scholar
10	Kale AD, Mane DR and Shukla D: Expression of transforming growth factor β and its correlation with lipodystrophy in oral submucous fibrosis: An immunohistochemical study. Med Oral Patol Oral Cir Bucal. 18:e12–e18. 2013.PubMed/NCBI View Article : Google Scholar
11	Pant I, Rao SG and Kondaiah P: Role of areca nut induced JNK/ATF2/Jun axis in the activation of TGF-β pathway in precancerous Oral Submucous Fibrosis. Sci Rep. 6(34314)2016.PubMed/NCBI View Article : Google Scholar
12	Hsieh YP, Chen HM, Lin HY, Yang H and Chang JZ: Epigallocatechin-3-gallate inhibits transforming-growth-factor-β1-induced collagen synthesis by suppressing early growth response-1 in human buccal mucosal fibroblasts. J Formos Med Assoc. 116:107–113. 2017.PubMed/NCBI View Article : Google Scholar
13	Li J, Zhao TT, Zhang P, Xu CJ, Rong ZX, Yan ZY and Fang CY: Autophagy mediates oral submucous fibrosis. Exp Ther Med. 11:1859–1864. 2016.PubMed/NCBI View Article : Google Scholar
14	Chang JZ, Yang WH, Deng YT, Chen HM and Kuo MY: EGCG blocks TGFβ1-induced CCN2 by suppressing JNK and p38 in buccal fibroblasts. Clin Oral Investig. 17:455–461. 2013.PubMed/NCBI View Article : Google Scholar
15	Tkach M and Théry C: Communication by Extracellular Vesicles: Where We Are and Where We Need to Go. Cell. 164:1226–1232. 2016.PubMed/NCBI View Article : Google Scholar
16	Hu Y, Rao SS, Wang ZX, Cao J, Tan YJ, Luo J, Li HM, Zhang WS, Chen CY and Xie H: Exosomes from human umbilical cord blood accelerate cutaneous wound healing through miR-21-3p-mediated promotion of angiogenesis and fibroblast function. Theranostics. 8:169–184. 2018.PubMed/NCBI View Article : Google Scholar
17	Chen CY, Rao SS, Ren L, Hu XK, Tan YJ, Hu Y, Luo J, Liu YW, Yin H, Huang J, et al: Exosomal DMBT1 from human urine-derived stem cells facilitates diabetic wound repair by promoting angiogenesis. Theranostics. 8:1607–1623. 2018.PubMed/NCBI View Article : Google Scholar
18	Sjoqvist S, Kasai Y, Shimura D, Ishikawa T, Ali N, Iwata T and Kanai N: Oral keratinocyte-derived exosomes regulate proliferation of fibroblasts and epithelial cells. Biochem Biophys Res Commun. 514:706–712. 2019.PubMed/NCBI View Article : Google Scholar
19	Lou G, Yang Y, Liu F, Ye B, Chen Z, Zheng M and Liu Y: MiR-122 modification enhances the therapeutic efficacy of adipose tissue-derived mesenchymal stem cells against liver fibrosis. J Cell Mol Med. 21:2963–2973. 2017.PubMed/NCBI View Article : Google Scholar
20	Qu Y, Zhang Q, Cai X, Li F, Ma Z, Xu M and Lu L: Exosomes derived from miR-181-5p-modified adipose-derived mesenchymal stem cells prevent liver fibrosis via autophagy activation. J Cell Mol Med. 21:2491–2502. 2017.PubMed/NCBI View Article : Google Scholar
21	Zhu F, Chong Lee Shin OL, Pei G, Hu Z, Yang J, Zhu H, Wang M, Mou J, Sun J, Wang Y, et al: Adipose-derived mesenchymal stem cells employed exosomes to attenuate AKI-CKD transition through tubular epithelial cell dependent Sox9 activation. Oncotarget. 8:70707–70726. 2017.PubMed/NCBI View Article : Google Scholar
22	Wang L, Hu L, Zhou X, Xiong Z, Zhang C, Shehada HM, Hu B, Song J and Chen L: Exosomes secreted by human adipose mesenchymal stem cells promote scarless cutaneous repair by regulating extracellular matrix remodelling. Sci Rep. 7(13321)2017.PubMed/NCBI View Article : Google Scholar
23	Khan I, Kumar N, Pant I, Narra S and Kondaiah P: Activation of TGF-β pathway by areca nut constituents: A possible cause of oral submucous fibrosis. PLoS One. 7(e51806)2012.PubMed/NCBI View Article : Google Scholar
24	Yang SF, Hsieh YS, Tsai CH, Chen YJ and Chang YC: Increased plasminogen activator inhibitor-1/tissue type plasminogen activator ratio in oral submucous fibrosis. Oral Dis. 13:234–238. 2007.PubMed/NCBI View Article : Google Scholar
25	Ni WF, Tsai CH, Yang SF and Chang YC: Elevated expression of NF-kappaB in oral submucous fibrosis - evidence for NF-kappaB induction by safrole in human buccal mucosal fibroblasts. Oral Oncol. 43:557–562. 2007.PubMed/NCBI View Article : Google Scholar
26	Li X, Xie X, Lian W, Shi R, Han S, Zhang H, Lu L and Li M: Exosomes from adipose-derived stem cells overexpressing Nrf2 accelerate cutaneous wound healing by promoting vascularization in a diabetic foot ulcer rat model. Exp Mol Med. 50:1–14. 2018.PubMed/NCBI View Article : Google Scholar
27	Han P, Lai A, Salomon C and Ivanovski S: Detection of salivary small extracellular vesicles associated inflammatory cytokines gene methylation in gingivitis. Int J Mol Sci. 21(5273)2020.PubMed/NCBI View Article : Google Scholar
28	Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:156–159. 1987.PubMed/NCBI View Article : Google Scholar
29	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real time quantitative PCR and the 2 (Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
30	Rao AR and Das P: Evaluation of the carcinogenicity of different preparations of areca nut in mice. Int J Cancer. 43:728–732. 1989.PubMed/NCBI View Article : Google Scholar
31	Gupta PC and Warnakulasuriya S: Global epidemiology of areca nut usage. Addict Biol. 7:77–83. 2002.PubMed/NCBI View Article : Google Scholar
32	Cox SC and Walker DM: Oral submucous fibrosis. A review. Aust Dent J. 41:294–299. 1996.PubMed/NCBI View Article : Google Scholar
33	Chang MC, Lin LD, Wu HL, Ho YS, Hsien HC, Wang TM, Jeng PY, Cheng RH, Hahn LJ and Jeng JH: Areca nut-induced buccal mucosa fibroblast contraction and its signaling: A potential role in oral submucous fibrosis - a precancer condition. Carcinogenesis. 34:1096–1104. 2013.PubMed/NCBI View Article : Google Scholar
34	Chang YC, Tsai CH, Lai YL, Yu CC, Chi WY, Li JJ and Chang WW: Arecoline-induced myofibroblast transdifferentiation from human buccal mucosal fibroblasts is mediated by ZEB1. J Cell Mol Med. 18:698–708. 2014.PubMed/NCBI View Article : Google Scholar
35	Kondaiah P, Pant I and Khan I: Molecular pathways regulated by areca nut in the etiopathogenesis of oral submucous fibrosis. Periodontol 2000. 80:213–224. 2019.PubMed/NCBI View Article : Google Scholar
36	Han CY, Koo JH, Kim SH, Gardenghi S, Rivella S, Strnad P, Hwang SJ and Kim SG: Hepcidin inhibits Smad3 phosphorylation in hepatic stellate cells by impeding ferroportin-mediated regulation of Akt. Nat Commun. 7(13817)2016.PubMed/NCBI View Article : Google Scholar
37	Hu C, Dandapat A, Sun L, Khan JA, Liu Y, Hermonat PL and Mehta JL: Regulation of TGFbeta1-mediated collagen formation by LOX-1: Studies based on forced overexpression of TGFbeta1 in wild-type and lox-1 knock-out mouse cardiac fibroblasts. J Biol Chem. 283:10226–10231. 2008.PubMed/NCBI View Article : Google Scholar
38	Sheppard D: Transforming growth factor beta: A central modulator of pulmonary and airway inflammation and fibrosis. Proc Am Thorac Soc. 3:413–417. 2006.PubMed/NCBI View Article : Google Scholar
39	Angadi PV, Kale AD and Hallikerimath S: Evaluation of myofibroblasts in oral submucous fibrosis: Correlation with disease severity. J Oral Pathol Med. 40:208–213. 2011.PubMed/NCBI View Article : Google Scholar
40	Wynn TA and Ramalingam TR: Mechanisms of fibrosis: Therapeutic translation for fibrotic disease. Nat Med. 18:1028–1040. 2012.PubMed/NCBI View Article : Google Scholar
41	Dai JP, Zhu DX, Sheng JT, Chen XX, Li WZ, Wang GF, Li KS and Su Y: Inhibition of Tanshinone IIA, salvianolic acid A and salvianolic acid B on Areca nut extract-induced oral submucous fibrosis in vitro. Molecules. 20:6794–6807. 2015.PubMed/NCBI View Article : Google Scholar
42	Teixeira FG, Carvalho MM, Sousa N and Salgado AJ: Mesenchymal stem cells secretome: A new paradigm for central nervous system regeneration? Cell Mol Life Sci. 70:3871–3882. 2013.PubMed/NCBI View Article : Google Scholar
43	Xin H, Li Y and Chopp M: Exosomes/miRNAs as mediating cell-based therapy of stroke. Front Cell Neurosci. 8(377)2014.PubMed/NCBI View Article : Google Scholar
44	De Jong OG, Van Balkom BW, Schiffelers RM, Bouten CV and Verhaar MC: Extracellular vesicles: Potential roles in regenerative medicine. Front Immunol. 5:608. 2014.PubMed/NCBI View Article : Google Scholar
45	Xie C, Ji N, Tang Z, Li J and Chen Q: The role of extracellular vesicles from different origin in the microenvironment of head and neck cancers. Mol Cancer. 18:83. 2019.PubMed/NCBI View Article : Google Scholar
46	Sun X, Meng H, Wan W, Xie M and Wen C: Application potential of stem/progenitor cell-derived extracellular vesicles in renal diseases. Stem Cell Res Ther. 10:8. 2019.PubMed/NCBI View Article : Google Scholar
47	Li FX, Liu JJ, Xu F, Lin X, Zhong JY, Wu F and Yuan LQ: Role of tumor-derived exosomes in bone metastasis. Oncol Lett. 18:3935–3945. 2019.PubMed/NCBI View Article : Google Scholar
48	Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 9:654–659. 2007.PubMed/NCBI View Article : Google Scholar
49	Illeperuma RP, Ryu MH, Kim KY, Tilakaratne WM and Kim J: Relationship of fibrosis and the expression of TGF-β1, MMP-1, and TIMP-1 with epithelial dysplasia in oral submucous fibrosis. Oral Med Pathol. 15:21–28. 2010.
50	Hu L, Wang J, Zhou X, Xiong Z, Zhao J, Yu R, Huang F, Zhang H and Chen L: Exosomes derived from human adipose mensenchymal stem cells accelerates cutaneous wound healing via optimizing the characteristics of fibroblasts. Sci Rep. 6(32993)2016.PubMed/NCBI View Article : Google Scholar
51	Cai Y, Li J, Jia C, He Y and Deng C: Therapeutic applications of adipose cell-free derivatives: A review. Stem Cell Res Ther. 11(312)2020.PubMed/NCBI View Article : Google Scholar
52	Li Y, Zhang W, Gao J, Liu J, Wang H, Li J, Yang X, He T, Guan H, Zheng Z, et al: Adipose tissue-derived stem cells suppress hypertrophic scar fibrosis via the p38/MAPK signaling pathway. Stem Cell Res Ther. 7(102)2016.PubMed/NCBI View Article : Google Scholar
53	Chai CY, Song J, Tan Z, Tai IC, Zhang C and Sun S: Adipose tissue-derived stem cells inhibit hypertrophic scar (HS) fibrosis via p38/MAPK pathway. J Cell Biochem. 120:4057–4064. 2019.PubMed/NCBI View Article : Google Scholar